From 20 to 22 November 2025, Zurich hosted the 90th Annual Meeting of the Swiss Society of Pathology, a key event for the European pathology community. IHU RespirERA took part to present its latest advances in liquid biopsy applied to lung cancer.
A Major Scientific Event in Switzerland
Held at the Lake Side Congress Center, the 90th Annual Meeting of the Swiss Society of Pathology (SGPath/SSPath), also known as the 3rd Swiss Pathology Days, brought together pathologists, researchers and clinicians to explore current developments in the field.
Driven by young Swiss pathologists, with the support of the SGPath and the Swiss Division of the IAP, the event gathered the scientific community for three days of discussion on technological innovations, new diagnostic challenges and advances that benefit patient care.
Under the theme “Pathology in Transition”, the congress highlighted a discipline undergoing rapid transformation, shaped by digital pathology, artificial intelligence, and precision medicine.
Scientific Sessions Focused on the Future
The programme combined keynote lectures, hands-on workshops and interactive clinical cases across multiple specialties, including pulmonary pathology.
This diverse format allowed participants to strengthen their knowledge while discovering new technological tools that are reshaping daily practice in pathology laboratories.
IHU RespirERA Showcases Its Advances in Liquid Biopsy
Invited to share the institute’s expertise, Prof. Paul Hofman, Director of IHU RespirERA, presented the latest progress made by the institute in the field of liquid biopsy for lung cancer.
Liquid biopsy, which allows the analysis of circulating tumour material through a simple blood sample, represents a major shift in the diagnosis and monitoring of lung cancer.
These advances align with the mission of IHU RespirERA: accelerating access to less invasive and more precise diagnostic tools to improve patient care for respiratory diseases, particularly lung cancers.
